LCN2 and non-small cell lung carcinoma: Notably, the miR-200 family and Lipocalin-2 (LCN2) mRNA in exosomes could stratify patients with lung adenocarcinoma from individuals with benign lung disease, suggesting that these two RNAs may serve as potential diagnostic markers for the NSCLC (153).